View this email in your browser

FDA + DTC Advertising: Hear it Directly

The conversation around DTC advertising is changing fast… and now, you’ll hear directly from the source.

At the 2026 DTC National, we’re bringing something you won’t find anywhere else: A live, moderated discussion with a senior FDA representative.

This session will offer a rare opportunity to hear directly from FDA/OPDP on the future of DTC advertising and the regulatory direction ahead.

FDA Views on DTC Advertising

The FDA has agreed to speak at the DTC National to give its views on DTC Advertising and its regulatory plans. We will host a live moderated conversation with a senior FDA representative where your most pressing questions and challenges will be addressed in real time.

This is your chance to understand:

• How FDA is thinking about the future of DTC advertising

• What regulatory priorities may impact your campaigns

• Where scrutiny is increasing and what it means for marketers

• How to stay compliant while continuing to innovate

We are excited to have FDA/OPDP join us to directly engage with the industry.

Limited Time Offer!

We’re offering a limited-time discount to help you get this this event:


Use code 'DTCN26FDA' for 10% off April 21 (Single-Day) & Full Conference Passes


Offer expires Friday, April 3

Reserve Your Spot

This year’s program is built around the real issues shaping DTC today, including:

• FDA scrutiny and OPDP enforcement trends

• Real-world DTC pharma case studies from brands like Cologuard, Bayer, Stryker, Novartis, and more major pharma and medical device

• AI in creative development and the evolving patient journey

• Point-of-care growth and shifting media strategies

• Industry efforts to protect the future of DTC advertising

If you want clarity, direction, and real-world insight, this is where it happens.

📅 April 21–23, 2026

📍 Westin Copley Place, Boston

Carolyn Austring

Executive Director, Marketing, Oncology

Bayer

Speaker - Main Agenda



Sean Cunningham

President & CEO

VAB

Speaker - Main Agenda

Jeremy Truxal

VP of Marketing, Cologuard

Exact Sciences

Speaker - Main Agenda



Randy Keim

Senior Director, HCP & Consumer Marketing

Sanofi

Panelist - Main Agenda

Denise Campbell

VP Marketing Strategy, US Oncology and Enterprise Partnerships

Novartis

Speaker - Main Agenda

Kristine Saffrin

Associate Marketing Director, Patient Marketing

Alexion, AstraZeneca Rare Disease

Panelist - Main Agenda

Annie Foster

Group Director of Social Media Creative

Omnicom Health

Speaker - Main Agenda

Jason Alongi

Senior Director Consumer Marketing

Tarsus Pharmaceuticals, Inc.

Panelist - Main Agenda

Patrick James Lynch

CEO

Believe Limited

Speaker - Main Agenda

Jim Potter

Executive Director

Coalition for Healthcare Communication

Speaker - Main Agenda

Olivier Chateau

CEO

Health Union

Moderator - Main Agenda



Frank Chipman

Managing Director

Advanced Insights and Marketing

Moderator - Main Agenda

The Regulatory Crossroads: What FDA Action Means for DTC

Creative That Breaks Through the Formula

AI in Action: From Concept to Approval

Beyond Television: The Expanding Media Mix

Culture, Celebrities, and Influence in Healthcare

Patient Storytelling That Drives Action

Reaching Diverse and Underserved Audiences

Real-World Case Studies from Leading Brands

Interactive Breakouts: Practical Solutions for Marketers

Networking and Awards Celebrations